{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+comparison+group&page=2", "query": { "intervention": "Placebo comparison group", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+comparison+group&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-28T12:03:57.090Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00600171", "title": "Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "GW642444M", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 614, "start_date": "2007-12", "completion_date": "2008-09", "has_results": true, "last_update_posted_date": "2016-12-16", "last_synced_at": "2026-09-28T12:03:57.090Z", "location_count": 30, "location_summary": "Phoenix, Arizona • Fresno, California • Huntington Beach, California + 25 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00600171" }, { "nct_id": "NCT01229449", "title": "Ibuprofen/Acetaminophen Versus Nurofen Plus® and Panadeine® Extra Dental Pain Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Post-operative Pain" ], "interventions": [ { "name": "Ibuprofen/acetaminophen", "type": "DRUG" }, { "name": "Ibuprofen/acetaminophen (higher dose)", "type": "DRUG" }, { "name": "Nurofen Plus®", "type": "DRUG" }, { "name": "Panadeine® Extra", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Reckitt Benckiser LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 678, "start_date": "2009-01", "completion_date": "2009-09", "has_results": true, "last_update_posted_date": "2018-09-17", "last_synced_at": "2026-09-28T12:03:57.090Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01229449" }, { "nct_id": "NCT03463031", "title": "Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Seasonal Allergic Rhinitis (SAR)" ], "interventions": [ { "name": "GSP 301 NS", "type": "DRUG" }, { "name": "GSP 301 Placebo NS", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Glenmark Specialty S.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "6 Years to 11 Years" }, "enrollment_count": 446, "start_date": "2018-03-16", "completion_date": "2018-11-14", "has_results": true, "last_update_posted_date": "2019-10-08", "last_synced_at": "2026-09-28T12:03:57.090Z", "location_count": 32, "location_summary": "Mission Viejo, California • Ontario, California • Paramount, California + 26 more", "locations": [ { "city": "Mission Viejo", "state": "California" }, { "city": "Ontario", "state": "California" }, { "city": "Paramount", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03463031" }, { "nct_id": "NCT02019472", "title": "A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Arthritis, Rheumatoid" ], "interventions": [ { "name": "adalimumab 40 mg", "type": "BIOLOGICAL" }, { "name": "sirukumab 100 mg", "type": "BIOLOGICAL" }, { "name": "sirukumab 50 mg", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 559, "start_date": "2014-04-04", "completion_date": "2016-08-17", "has_results": true, "last_update_posted_date": "2017-10-26", "last_synced_at": "2026-09-28T12:03:57.090Z", "location_count": 42, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Arvin, California + 39 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Arvin", "state": "California" }, { "city": "El Cajon", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02019472" }, { "nct_id": "NCT00917501", "title": "Neurochemical Effects of Omega-3 Fatty Acids in Adolescents at Risk for Mania", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Mania" ], "interventions": [ { "name": "OMega 3", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "10 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "10 Years to 21 Years" }, "enrollment_count": 55, "start_date": "2009-06", "completion_date": "2013-07", "has_results": true, "last_update_posted_date": "2019-11-13", "last_synced_at": "2026-09-28T12:03:57.090Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00917501" }, { "nct_id": "NCT03606057", "title": "A Study to Investigate the Effect of JNJ-64565111 on Cardiac Repolarization (Corrected QT Interval) Compared With Placebo in Healthy Adults: a Thorough ECG Study Employing Placebo, JNJ-64565111, and a Positive Control (Moxifloxacin)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "JNJ-64565111", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "JNJ-64565111-matching Placebo", "type": "DRUG" }, { "name": "Moxifloxacin-matching Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 188, "start_date": "2018-07-13", "completion_date": "2019-02-28", "has_results": false, "last_update_posted_date": "2020-03-03", "last_synced_at": "2026-09-28T12:03:57.090Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT03606057" }, { "nct_id": "NCT01555073", "title": "Preemptive Analgesia Following Uterine Artery Embolization", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Uterine Fibroids", "Uterine Artery Embolization" ], "interventions": [ { "name": "pregabalin/celecoxib", "type": "DRUG" }, { "name": "pregabalin/placebo", "type": "DRUG" }, { "name": "celecoxib/placebo", "type": "DRUG" }, { "name": "Placebo group", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "18 Years to 65 Years · Female only" }, "enrollment_count": 23, "start_date": "2011-10", "completion_date": "2013-10", "has_results": true, "last_update_posted_date": "2016-07-28", "last_synced_at": "2026-09-28T12:03:57.090Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01555073" }, { "nct_id": "NCT01131676", "title": "BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "BI 10773 low dose", "type": "DRUG" }, { "name": "Placebo BI 10773 high dose", "type": "DRUG" }, { "name": "BI 10773 high dose", "type": "DRUG" }, { "name": "Placebo BI 10773 low dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7064, "start_date": "2010-07", "completion_date": "2015-04", "has_results": true, "last_update_posted_date": "2016-05-16", "last_synced_at": "2026-09-28T12:03:57.090Z", "location_count": 170, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 140 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Little Rock", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT01131676" }, { "nct_id": "NCT00603278", "title": "A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "GW685698X", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 622, "start_date": "2007-12", "completion_date": "2008-11", "has_results": true, "last_update_posted_date": "2016-12-28", "last_synced_at": "2026-09-28T12:03:57.090Z", "location_count": 95, "location_summary": "Phoenix, Arizona • Fort Smith, Arkansas • Little Rock, Arkansas + 82 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fresno", "state": "California" }, { "city": "Granada Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00603278" }, { "nct_id": "NCT02907177", "title": "Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Multiple Sclerosis" ], "interventions": [ { "name": "Ponesimod", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Actelion", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 136, "start_date": "2017-03-30", "completion_date": "2020-03-26", "has_results": true, "last_update_posted_date": "2021-05-18", "last_synced_at": "2026-09-28T12:03:57.090Z", "location_count": 26, "location_summary": "Birmingham, Alabama • Fresno, California • Pasadena, California + 22 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fresno", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "Santa Clarita", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02907177" } ] }